What they were paid
Niagen Bioscience Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $45,000 | — | $198,076 | $0 | $243,076 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Niagen Bioscience, Inc. DEF 14A filed April 29, 2026, accession 0001386570-26-000022, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Niagen Bioscience pays directors a $40,000 cash retainer and $20,000 in Options.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the Niagen Bioscience board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Ann Cohen | Independent Director | $265,576 |
| Frank Jaksch Jr | Chair of the Board | $268,076 |
| Gary Ng | Independent Director | $245,576 |
| Hamed Shahbazi | Independent Director | $243,076 |
| Kristin Patrick | Independent Director | $258,076 |
| Robert Fried | Director | $0 |
| Steven Rubin | Lead Independent Director | $293,076 |
The full Niagen Bioscience compensation record
free company briefThis page is one director within Niagen Bioscience's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat